These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20216313)

  • 1. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
    Marur S; Forastiere AA
    Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy for head and neck cancer: latest developments and future perspectives.
    Bernier J; Bentzen SM
    Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of treatments for head and neck squamous cell carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():85-96. PubMed ID: 10410663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
    Rosenthal DI; Blanco AI
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targeted therapies in all histologies of head and neck cancers: an update.
    Razak AR; Siu LL; Le Tourneau C
    Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supportive care in head and neck oncology.
    de Castro G; Guindalini RS
    Curr Opin Oncol; 2010 May; 22(3):221-5. PubMed ID: 20186057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.
    Bernier J
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1193-208, ix. PubMed ID: 19010268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for head and neck cancer.
    Rhee JC; Khuri FR; Shin DM
    Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting important pathways in head and neck cancer: from the bench to the clinic.
    Santos ES; Perez C; Donald CE; Raez LE
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1819-35. PubMed ID: 18983242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
    Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy in head and neck cancer: a new paradigm.
    Pointreau Y; Atean I; Fayette J; Calais G; Lefebvre JL
    Anticancer Drugs; 2011 Aug; 22(7):613-20. PubMed ID: 21160420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.
    Ramos M; Benavente S; Giralt J
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):339-44. PubMed ID: 20214515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
    Gilbert J; Argiris A
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of clinical trials in head and neck cancer.
    Yang ES; Murphy BM; Chung CH; Netterville JL; Burkey BB; Gilbert J; Yarbrough WG; Sinard R; Cmelak AJ
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):29-42. PubMed ID: 18996026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial design limitations in head and neck squamous cell carcinomas.
    Yun HJ; Bogaerts J; Awada A; Lacombe D
    Curr Opin Oncol; 2007 May; 19(3):210-5. PubMed ID: 17414638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.